Quantitative Measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody-positive nonclinical dogs

Clinical and Vaccine Immunology

Volumn 15, Issue 1, 2008, Pages 115-119

  Levy, Steven A ^a   O'Connor, Thomas P ^b   Hanscom, Jancy L ^b   Shields, Paulette ^b   Lorentzen, Leif ^b   DiMarco, Anthony A ^b  

^a Durham Veterinary Hospital   (United States)

^b IDEXX LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; C6 ANTIBODY; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; LIPOPROTEIN; OLIGOPEPTIDE; PEPTIDE FRAGMENT; VLSE PROTEIN, BORRELIA BURGDORFERI;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; DOG; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ANIMAL; ANIMAL DISEASE; ANTIBODY SPECIFICITY; BLOOD; DOG DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LYME DISEASE; METHODOLOGY; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LIPOPROTEINS; LYME DISEASE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS;

EID: 43149118373     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00340-07     Document Type: Article

References (23)

1. Bacon, R. M., B. J. Biggerstaff, M. E. Schriefer, R. D. Gilmore, M. T. Philipp, A. S. Steere, G. P. Wormser, A. R. Marques, and B. J. Johnson. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis. 187:1187-1189.
2. Brorson, O., and S. H. Brorson. 1997. Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes. Infection 25:240-246.
3. Centers for Disease Control and Prevention. 2002. Lyme disease - United States, 2000. Morb. Mortal. Wkly. Rep. 51:29-31.
4. 6 antibodies in dogs from southeastern and mid-Atlantic states. Vector Borne Zoonotic Dis. 4:221-229.
5. Lawrenz, M. B., J. M. Hardham, R. T. Owens, J. Nowakowski, A. C. Steere, G. P. Worsmer, and S. J. Norris. 1999. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37:3997-4004.
6. Levy, S. A., S. W. Barthold, D. M. Dombach, and T. L. Wasmoen. 1993. Canine Lyme borreliosis. Compend. Contin. Educ. Pract. Vet. 15:833-848.
7. 6 ELISA test kit for the determination of infection status of dogs naturally exposed to Borrelia burgdorferi. Vet. Ther. 3:308-315.
8. 6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted Borrelia burgdorferi infection. Vet. Ther. 3:420-424.
9. Liang, F. T., A. C. Steere, A. R. Marques, B. J. Johnson, J. N. Miller, and M. T. Phlipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
10. Liang, F. T., and M. T. Philipp. 1999. Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect. Immun. 67:6702-6706.
11. Liang, F. T., R. H. Jacobsen, R. K. Straubinger, A. Grooters, and M. T. Philipp. 2000. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 38:4160-4166.
12. Lissman, B. A., E. M. Bosler, H. Camay, B. G. Ormiston, and J. L. Benach. 1984. Spirochete-associated arthritis (Lyme disease) in a dog. J. Am. Vet. Med. Assoc. 185:210-220.
13. Marangoni, A. M., V. Sambri, S. Accardo, F. Cavrini, V. Mondardini, A. Moroni, E. Storni, and R. Cevenini. 2006. A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease. Clin. Vaccine Immunol. 13:525-529.
14. 6 Lyme antibody test for laboratory detection of Lyme disease. Clin. Diagn. Lab. Immunol. 11:924-929.
15. 6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi. Clin. Diagn. Lab. Immunol. 11:458-462.
16. 6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J. Infect. Dis. 184:870-878.
17. 6 test as an indicator of therapy outcome for patients with localized or disseminated Lyme borreliosis. J. Clin. Microbiol. 41:4955-4960.
18. 6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme borreliosis. Clin. Diagn. Lab. Immunol. 12:1069-1074.
19. Rondeau, M. P., R. M. Walton, S. Bissett, K. J. Drobatz, and R. J. Washabau. 2005. Suppurative, nonseptic polyarthropathy in dogs. J. Vet. Intern. Med. 19:654-662.
20. Straubinger, R. K., A. F. Straubinger, B. A. Summers, and R. H. Jacobson. 2000. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: an experimental study. J. Vet. Intern. Med. 181:1069-1081.
21. Straubinger, R. K., B. A. Summers, Y. F. Chang, and M. J. Appel. 1997. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J. Clin. Microbiol. 35:111-116.
22. Straubinger, R. K. 2000. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. J. Clin. Microbiol. 38:2191-2199.
23. Summers, B. A., A. F. Straubinger, R. H. Jacobson, Y. F. Chang, M. J. Appel, and R. K. Straubinger. 2005. Histopathological studies of experimental Lyme disease in the dog. J. Comp. Pathol. 133:1-13.